Investment Summary

1315 Capital Invests In Innovative ECMO Concepts

On October 4, 2022, growth capital firm 1315 Capital invested in education company Innovative ECMO Concepts

Investment Highlights
  • This is 1315 Capital’s 1st transaction in the Education sector.
  • This is 1315 Capital’s 17th transaction in the United States.
  • This is 1315 Capital’s 1st transaction in Oklahoma.

Investment Summary
Date 2022-10-04
Target Innovative ECMO Concepts
Sector Education
Investor(s) 1315 Capital
Deal Type Growth Capital

Target

Innovative ECMO Concepts

Arcadia, Oklahoma, United States
Innovative ECMO Concepts is a staffing and training company that provides outsourced support for extracorporeal membrane oxygenation (ECMO) and perfusion in hospitals. Innovative ECMO Concepts was founded in 2014 and is based in Arcadia, Oklahoma.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

1315 Capital

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 2014
Size Small
Type Sector Focused
DESCRIPTION

1315 Capital is a private investment firm that provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare service companies. The Firm will consider opportunities across the US and generally looks to commit $10 to $40 million per investment. 1315 Capital was formed in 2014 and is based in Philadelphia, Pennsylvania.

DEAL STATS #
Overall 19 of 21
Sector (Education) 1 of 1
Type (Growth Capital) 5 of 6
State (Oklahoma) 1 of 1
Country (United States) 17 of 19
Year (2022) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-07-13 Nutrisense

Chicago, Illinois, United States

Nutrisense is a nutrition technology company helping its users improve their metabolic health through personalized data and dietitian support. Nutrisense was founded in 2019 and is based in Chicago, Illinois.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-11-02 Biocoat

Horsham, Pennsylvania, United States

Biocoat develops and licenses biomaterial coatings for medical devices that are custom engineered to meet specific clinical parameters. The company specializes in supplying lubricious hydrophilic coatings for medical devices to original equipment manufacturers and contract manufacturers. Biocoat is able to recommend contract coaters or to provide in-house coating services to aspiring medical device companies that need help with manufacturing. The company also sells diagnostic test kits in the reproductive market for use in male factor infertility. Biocoat was founded in 1991 and is based in Horsham, Pennsylvania.

Sell -
Mergr

Product

Company

Legal